These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25392156)

  • 1. The role of chemotherapy for metastatic, relapsed and refractory osteosarcoma.
    Xiao X; Wang W; Wang Z
    Paediatr Drugs; 2014 Dec; 16(6):503-12. PubMed ID: 25392156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of pirarubicin-based versus gemcitabine-docetaxel chemotherapy for relapsed and refractory osteosarcoma: a single institution experience.
    He A; Qi W; Huang Y; Sun Y; Shen Z; Zhao H; Yang Y; Yao Y
    Int J Clin Oncol; 2013 Jun; 18(3):498-505. PubMed ID: 22534798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OLIE, ITCC-082: a Phase II trial of lenvatinib plus ifosfamide and etoposide in relapsed/refractory osteosarcoma.
    Gaspar N; Campbell-Hewson Q; Huang J; Okpara CE; Bautista F
    Future Oncol; 2021 Nov; 17(32):4249-4261. PubMed ID: 34382412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An autopsy case of pulmonary and central nervous system metastatic osteosarcoma treated with thirty-six courses of chemotherapy over four years].
    Ito T; Mochida A; Saito K; Nishi K; Sasaki S; Hisada T; Morinari H; Nakahara K; Tahara M; Masuda S; Yakumaru K
    Nihon Kokyuki Gakkai Zasshi; 2002 Jan; 40(1):71-6. PubMed ID: 11925923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of gemcitabine and docetaxel chemotherapy for the treatment of relapsed and refractory osteosarcoma: A systematic review and pre-clinical study.
    Low K; Foulkes P; Hills F; Roberts HC; Stordal B
    Cancer Med; 2024 Sep; 13(18):e70248. PubMed ID: 39315544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
    Choeyprasert W; Pakakasama S; Sirachainan N; Songdej D; Chuansumrit A; Anurathapan U; Hongeng S; Nartthanarung A
    Asian Pac J Cancer Prev; 2014; 15(22):9823-9. PubMed ID: 25520112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of refractory osteosarcoma with fractionated cyclophosphamide and etoposide.
    Rodríguez-Galindo C; Daw NC; Kaste SC; Meyer WH; Dome JS; Pappo AS; Rao BN; Pratt CB
    J Pediatr Hematol Oncol; 2002 May; 24(4):250-5. PubMed ID: 11972091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ifosfamide and etoposide in childhood osteosarcoma. A phase II study of the French Society of Paediatric Oncology.
    Gentet JC; Brunat-Mentigny M; Demaille MC; Pein F; Avet-Loiseau H; Berger C; De Lumley L; Pacquement H; Schmitt C; Sariban E; Pillon P; Bernard JL; Kalifa C
    Eur J Cancer; 1997 Feb; 33(2):232-7. PubMed ID: 9135494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study.
    Gaspar N; Venkatramani R; Hecker-Nolting S; Melcon SG; Locatelli F; Bautista F; Longhi A; Lervat C; Entz-Werle N; Casanova M; Aerts I; Strauss SJ; Thebaud E; Morland B; Nieto AC; Marec-Berard P; Gambart M; Rossig C; Okpara CE; He C; Dutta L; Campbell-Hewson Q
    Lancet Oncol; 2021 Sep; 22(9):1312-1321. PubMed ID: 34416158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher Gemcitabine Dose Was Associated With Better Outcome of Osteosarcoma Patients Receiving Gemcitabine-Docetaxel Chemotherapy.
    Lee JA; Jeon DG; Cho WH; Song WS; Yoon HS; Park HJ; Park BK; Choi HS; Ahn HS; Lee JW; Yoo KH; Sung KW; Koo HH; Kang HJ; Park KD; Shin HY; Koh KN; Im HJ; Seo JJ; Lim YJ; Baek HJ; Kook H
    Pediatr Blood Cancer; 2016 Sep; 63(9):1552-6. PubMed ID: 27197055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pilot study of relapsed osteosarcoma and brain tumor with ifosfamide, carboplatin and etoposide (ICE therapy)].
    Hirota T; Takeuchi M; Iwata A; Kitagawa S; Sato T; Konno K; Sawada K; Kobayashi S; Hamaguchi N; Agata H; Katano N; Fujimoto T
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):385-90. PubMed ID: 9492832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy and gemcitabine-docetaxel chemotherapy in children and adolescents with unresectable recurrent or refractory osteosarcoma.
    Lee JA; Paik EK; Seo J; Kim DH; Lim JS; Yoo JY; Kim MS
    Jpn J Clin Oncol; 2016 Feb; 46(2):138-43. PubMed ID: 26685322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors.
    Nieto Y; Tu SM; Bassett R; Jones RB; Gulbis AM; Tannir N; Kingham A; Ledesma C; Margolin K; Holmberg L; Champlin R; Pagliaro L
    Ann Oncol; 2015 Oct; 26(10):2125-32. PubMed ID: 26199392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of gemcitabine-docetaxel combination therapy for recurrent or refractory high-grade osteosarcoma in China: a retrospective study of 18 patients.
    Qi WX; He AN; Tang LN; Shen Z; Lin F; Yao Y
    Jpn J Clin Oncol; 2012 May; 42(5):427-31. PubMed ID: 22450929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
    Meyers PA; Schwartz CL; Krailo MD; Healey JH; Bernstein ML; Betcher D; Ferguson WS; Gebhardt MC; Goorin AM; Harris M; Kleinerman E; Link MP; Nadel H; Nieder M; Siegal GP; Weiner MA; Wells RJ; Womer RB; Grier HE;
    J Clin Oncol; 2008 Feb; 26(4):633-8. PubMed ID: 18235123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
    Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
    Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ifosfamide-containing regimens for treating patients with osteosarcomas.
    Li YY; Jiang XM; Dong YG; Xu G; Ma YB
    Asian Pac J Cancer Prev; 2014; 15(22):9763-6. PubMed ID: 25520101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous-infusion ifosfamide and doxorubicin combination as second-line chemotherapy for recurrent or refractory osteosarcoma patients in China: a retrospective study.
    Huang YJ; He AN; Sun YJ; Shen Z; Min DL; Yao Y
    Asian Pac J Cancer Prev; 2015; 16(6):2391-5. PubMed ID: 25824770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series.
    Palmerini E; Setola E; Grignani G; D'Ambrosio L; Comandone A; Righi A; Longhi A; Cesari M; Paioli A; Hakim R; Pierini M; Marchesi E; Vanel D; Pignochino Y; Donati DM; Picci P; Ferrari S
    Cells; 2020 Oct; 9(11):. PubMed ID: 33142760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.